re: coramsine/saxien Saxien , not much in depth info there to change my mind on this stock . Just more of the BS you are fond of quoting . Clinical trials are conducted by an independent trial doctor who answers to the TGA . The doctor in this case is Michael Millward , a highly respected clinical trial oncology professor . He has recently been assosciated with the Genasense trial of 771 patients at 139 sites in 9 countries , and it was him who presented the info at ASCO . He is among he top in his field . So I think even you Saxien can see that the BS pretty much stops when that trial starts .
First you whinge about Solbecs choice of a miner to come to market , then you whinge when the miners on the board are replaced . THE ONLY PEOPLE ON THE BOARD OF SOLBEC ARE MEDICAL , LAW AND A BROKER .
The latest board addition is Dr Hung , U.S. based with a broad experience in US biotechs , including running a successful US biotech play right through to takeover . Prof Papadimitriou has the Order of Australia for services to medical research and Steve Carter , who deserves most of the credit for getting this drug to this stage in record time with a cash burn rate a fraction of most are the other medical board members. They also have association with Professor Bruce Robinson , one of the worlds top mesothelioma experts and Dr Robert Nagourney , the recently appointed Director of the new Todd Cancer Institute , Long Beach , one of the largest private hospitals in the USA . It was Dr Nagourney who first presented Solbecs data at ASCO and AACR
You say there is no urgency apparent . What would you call the prelims for the phase 2 trials that were started long before the phase 1 is complete , a psoriasis trial running concurrently and ongoing efforts to license off the veterinary and diagnostic technologies .
They recently presented at the most important biotech partnering conference in the USA , and have just presented at the Ausbio conference . The presentation from the Techvest is on the website , and if you take the time to actually read it you may see the value in this company .
The results so far from the clinical trials require no comment , they speak for themselves . Solbec is at the world forefront of this new glyco technology and I think I will keep my shares for now . Phase 1/2a results just round the corner in both psoriasis and cancer .
Cheers .
- Forums
- ASX - By Stock
- SBP
- coramsine
SBP
solbec pharmaceuticals limited
coramsine, page-7
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SBP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online